Dr. Simon Kos
Chief Medical Officer
Dr. Simon Kos is Chief Medical Officer and Senior Director, Worldwide Health, Microsoft. In this key executive role, Dr. Kos is responsible for providing clinical guidance, thought leadership, vision and strategy for Microsoft technologies and solutions in the Health and Healthcare industries. He works with industry partners and healthcare organizations around the world to improve and transform health outcomes by leveraging technology and innovation. Dr. Kos joined Microsoft in 2010, bringing his expertise to the Australian health team after 17 years in the health and health IT industries. As the doctor on Microsoft’s health team, he was responsible for health strategy and industry engagement. He raised awareness of the Microsoft brand, technologies, and partner community, and he works to find clinical relevance for Microsoft products.
Prior to Microsoft, Dr. Kos worked with global health IT companies Cerner and InterSystems as they implemented some of the largest e-Health initiatives in Australia. Before his career in health IT, Dr. Kos practiced at NSWHealth for several years with a focus on critical care. Simon has an MBBS and a BSc (Med) from the University of New South Wales, as well as an MBA with a major in change management from the Australian Graduate School of Management. He is passionate about improving healthcare through technology.
Dr. Gene Dantkser
Qualcomm Life, Inc.
Dr. Dantsker is responsible for enabling intelligent integrated care models through the Internet of Medical Things (IoMT) in the pharmaceutical, medical device, diagnostics and payer industries. Prior to this role, Dr. Dantsker worked across the spectrum of therapy and diagnostic technology solutions with broad experience in healthcare, biotech and semiconductor businesses. Formerly, he was a senior technical staff member at TRW, Inc., Space and Electronics Division where he was responsible for design, fabrication, and integration of microelectronics for space/satellite applications.
Subsequently he co-founded Nanostream, Inc., a biotechnology company and provider of high-throughput bio-analytical instruments to pharmaceutical companies and CROs. As VP of Technology, Dr. Dantsker was co-inventor and developer of Nanostream’s core technologies based on polymer MEMS microfluidics and converted them into commercial products purchased by leading pharmaceutical companies. He also served as CEO and CTO of aDNAvance Technologies, Inc., a provider of ultra-sensitive medical molecular diagnostic products. Dr. Dantsker served on the Board of Directors of D-Wave Systems, a pioneer in Quantum Computing, with leading Silicon Valley VCs, as well as heavily consulted the company in business development, IP strategy, growth strategy and operational infrastructure.
Associate Director, Office of Device Evaluation, Center for Devices and Radiologic Health
U.S. Food and Drug Administration
Linda Ricci began her career developing artificial intelligence solutions in the defense industry before moving to the medical device industry as a software engineer. She helped to develop several diagnostic cardiology devices and has participated in all phases of product life cycle development. Ms. Ricci moved to the FDA in 2005 and has had several roles including scientific reviewer and branch chief within the Division of Cardiovascular devices. Currently Ms. Ricci is the Associate Director for Digital Health within the Office of Device Evaluation. In this role she, leads the development and implementation of digital health policy within the Office of Device Evaluation. She has degrees in Electrical Engineering and Medical Engineering.
Health Business Leader of the Americas
Desmond Creary is currently the Health Business Leader of the Americas at Microsoft. He previously held several positions at GSK including Vice President of Sales, Primary Care, Field Vice President, and Project Manager for the CEO's Future Strategy Group. He has a degree in marketing from the Southern University and Agricultural and Mechanical College at Baton Rouge and an MBA from the University of Phoenix
Associate Vice President, DDO Business Operations
(FACT, Reporting/Analytics & Resourcing)
Sarah’s varied background and experience in her 25+ years in the pharmaceutical industry has given her a broad perspective in which she shares with her colleagues daily. Prior to joining Allergan, Sarah spent ~20 years with Schering Plough (now Merck) starting off as a site monitor and progressing throughout the Clinical Development organization. Sarah also oversaw all Global Early Stage Development Operations at Schering Plough. Sarah then transitioned to Forest where she has overseen various groups within Drug Development Operations from Recruitment and Vendor Management, to her current role as Head of DDO Business Operations overseeing, among others, Feasibility Analysis for Clinical Trials (FACT) and Systems and Reporting.
Chief Digital Officer-Health & Wellness
Ogilvy CommonHealth Worldwide
Ritesh is the Chief Digital Officer at Ogilvy CommonHealth Worldwide, a global marketing services company offering advertising and promotion, brand identity and development, digital marketing, market access, medical education, PR, and strategy and planning. Prior to Ogilvy, he spent 5 years as the Global Head of Digital and Innovation for inVentiv Health, a global healthcare services organization with offices in 40 countries. Ritesh is a Digital and Social Evangelist and a geek at heart. With over 18 years of digital experience his background includes Online Marketing, Advertising, Sales, CRM and E-Business. He focuses primarily on digital strategy, tools, platforms, and ecosystems in Healthcare.
Senior Program Manager: Project InnerEye
Mr. Tarapov is a program manager for Project InnerEye at Microsoft Research. Prior to joining Microsoft Ivan has worked with a number of medical device companies with high-risk devices such as cardiac defibrillators, insulin pumps and deep brain stimulators.
Chief Commercial and Strategy Officer
Peyton Howell joined PAREXEL as Chief Commercial and Strategy Officer in May 2018 and is responsible for leading PAREXEL’s commercial operations to enhance the customer experience. Ms. Howell’s distinguished career spans over 25 years of delivering solutions that meet the needs of customers in the healthcare industry.
Ms. Howell previously held several leadership positions with AmerisourceBergen as Executive Vice President and President, Health Systems and Specialty Care Solutions, leading a business unit with market leading share of specialty and biotech products and solutions to physicians, health systems and specialty pharmacy customers. Prior to that, she served as Executive Vice President and President, Global Sourcing and Manufacturer Relations, in which she led all pharmaceutical manufacturer procurement strategy for AmerisourceBergen, including multi-billion dollar sourcing activities.
Chief Information Officer
Mr. Barta currently serves as Chief Information Officer, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
Previously Mr. Barta served as CIO of Guy Carpenter, a Marsh & McLennan company and a global leader in providing risk and reinsurance intermediary services. Prior to this position, he served as Chief Operating Officer of Fidelity Investment Management Technology with Fidelity Investments, where he ran operations for Asset Management’s technology division. Mr. Barta also served as SVP IT Transformation and as SVP CFIT, Fidelity’s financial systems business where he held leadership responsibility for Fidelity's ERP and reporting environments as well as spearheading the effort to create and deploy a comprehensive cost and profitability platform.